SEC Form 4 · accession 0000914190-26-000096
BIO-TECHNE Corp · TECH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Steven C. Crouse
Officer — President - Diag & Spatial Bi
Period of report
Jun 2, 2026
Accepted (ET)
Jun 4, 2026 · 4:28 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0000842023
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F17 | Jun 2, 2026 | M | 600 | — | A | 6,977 | D | |
| Common Stock | Jun 2, 2026 | F | 216 | $49.77 | D | 6,761 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF1,F3 | — | Jun 2, 2026 | M | 600 | D | — | — | Common Stock | 600 | 1,200 | D |
| Restricted Stock UnitsF1,F2 | — | holding | — | — | — | — | — | Common Stock | 794 | 794 | D |
| Restricted Stock UnitsF1,F4 | — | holding | — | — | — | — | — | Common Stock | 1,379 | 1,379 | D |
| Restricted Stock UnitsF1,F5 | — | holding | — | — | — | — | — | Common Stock | 3,737 | 3,737 | D |
| Restricted Stock UnitsF1,F6 | — | holding | — | — | — | — | — | Common Stock | 6,529 | 6,529 | D |
| Stock Option (right to buy)F7 | $97.13 | holding | — | — | — | — | Apr 1, 2028 | Common Stock | 3,856 | 3,856 | D |
| Stock Option (right to buy)F7 | $120.46 | holding | — | — | — | — | Aug 6, 2028 | Common Stock | 19,032 | 19,032 | D |
| Stock Option (right to buy)F8 | $94.52 | holding | — | — | — | — | Aug 15, 2029 | Common Stock | 24,560 | 24,560 | D |
| Stock Option (right to buy)F9 | $84.61 | holding | — | — | — | — | Aug 15, 2030 | Common Stock | 12,649 | 12,649 | D |
| Stock Option (right to buy)F10 | $73.46 | holding | — | — | — | — | May 1, 2031 | Common Stock | 7,327 | 7,327 | D |
| Stock Option (right to buy)F11 | $74.91 | holding | — | — | — | — | Aug 15, 2034 | Common Stock | 17,133 | 17,133 | D |
| Stock Option (right to buy)F12 | $48.61 | holding | — | — | — | — | Jun 2, 2035 | Common Stock | 5,434 | 5,434 | D |
| Stock Option (right to buy)F13 | $53.60 | holding | — | — | — | — | Aug 15, 2035 | Common Stock | 19,151 | 19,151 | D |
| Performance Restricted Stock UnitsF1,F14 | — | holding | — | — | — | — | — | Common Stock | 2,387 | 2,387 | D |
| Restricted Stock UnitsF1,F15 | — | holding | — | — | — | — | — | Common Stock | 735 | 735 | D |
| Stock Option (right to buy)F16 | $57.82 | holding | — | — | — | — | Mar 2, 2036 | Common Stock | 1,911 | 1,911 | D |
Explanation of responses
- F1Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
- F10Options to purchase 1,832 shares vest on each of 5/1/2025, 5/1/2026 and 5/1/2028; and options to purchase 1,831 shares vest on 5/1/2027.
- F11Options to purchase 4,283 shares vest on each of 8/15/2025, 8/15/2027 and 8/15/2028; and options to purchase 4,284 shares vest on 8/15/2026.
- F12Options to purchase 1,359 shares vest on each of 6/2/2026 and 6/2/2028; and options to purchase 1,358 shares vest on each of 6/2/2027 and 6/2/2029.
- F13Options to purchase 4,788 shares vest on each of 8/15/2026, 8/15/2027 and 8/15/2029; and options to purchase 4,787 shares vest on 8/15/2028.
- F14Vests in full or in part on 8/15/2028 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
- F15245 restricted stock units vest on 3/2/2027, 3/2/2028 and 3/2/2029.
- F16Options to purchase 478 shares vest on each of 3/2/2027, 3/2/2028 and 3/2/2030; and options to purchase 477 shares vest on 3/2/2029.
- F17Due to a mathematical error on the Form 4 filed May 5, 2026, the number of shares beneficially owned is being increased by 40 shares and this filing represents the correct number of shares beneficially owned by the Reporting Person.
- F2794 restricted stock units vest on 5/1/2027.
- F3600 restricted stock units vest on each of 6/2/2026, 6/2/2027 and 6/2/2028.
- F41,379 restricted stock units vest on 8/15/2026.
- F51,868 restricted stock units vest on 8/15/2026 and 1,869 restricted stock units vest on 8/15/2027.
- F62,176 restricted stock units vest on each of 8/15/2026 and 8/15/2028; and 2,177 restricted stock units vest on 8/15/2027.
- F7100% vested.
- F8Options to purchase 6,140 shares vest on each of 8/15/2023, 8/15/2024, 8/15/2025 and 8/15/2026.
- F9Options to purchase 3,162 shares vest on each of 8/15/2024, 8/15/2026 and 8/15/2027; and options to purchase 3,163 shares vest on 8/15/2025.